navigo workstation
uc-care ltd. - רופא - the uc-care navigotm workstation is intended to be used by physicians in the clinic or hospital for 2-d and 3-d visualization of ultrasound images of the prostate gland. additional software features assist biopsy procedures include patient data management, multi-planar reconstruction, segmentation, image measurement and 3-d image registration. the device is specifically indicated for reconstruction of a 3d rendered surface model of the prostate and to display locations for biopsies that have been selected by the physician, as well as storage and future retrieval of this information. the expected system accuracy is ±5 mm. this includes the accuracy of the prostate surface that is presented to the practitioner over the navigotm workstation screen during 3d model reconstructions and also the accuracy of the biopsy needle trajectory that is presented to the practitioner over the navigotm workstation screen during the biopsy session. all clinical decisions taken regarding the use of the uc-care navigo™ workstation
טוקטינו 10 מג
glaxo smith kline (israel) ltd - alitretinoin - קפסולות רכות - alitretinoin 10 mg - alitretinoin - alitretinoin - for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .
טוקטינו 30 מג
glaxo smith kline (israel) ltd - alitretinoin - קפסולות רכות - alitretinoin 30 mg - alitretinoin - alitretinoin - for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .
פרוסטין אי2 ג'ל וגינלי 1 מג
pfizer pfe pharmaceuticals israel ltd - dinoprostone - ג'ל - dinoprostone 0.033 %w/w - dinoprostone - dinoprostone - for labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation
פרוסטין אי2 ג'ל וגינלי 2 מג
pfizer pfe pharmaceuticals israel ltd - dinoprostone - ג'ל - dinoprostone 0.066 %w/w - dinoprostone - dinoprostone - for labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation
טסטומקס 25 מג
padagis israel pharmaceuticals ltd, israel - testosterone - ג'ל - testosterone 25 mg/dose - testosterone - testosterone - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
אנדרוג'ל 50 מג
cts ltd - testosterone - ג'ל - testosterone 0.05 mg/sachet - testosterone - testosterone - testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
טסטומקס 50 מג
padagis israel pharmaceuticals ltd, israel - testosterone - ג'ל - testosterone 50 mg/dose - testosterone and estrogen - testosterone and estrogen - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
סנדוסטטין 0.1 מגמל
novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.
סנדוסטטין 0.2 מגמל
novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.2 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.